突発性難聴難治例に対するプロスタグランディンI2製剤を用いた二次治療の検討

DOI Web Site 参考文献33件

書誌事項

タイトル別名
  • Effects of Oral Administration of Prostaglandin I2 as a Salvage Treatment in Patients with Sudden Deafness
  • ヤクブツ トッパツセイ ナンチョウ ナンチレイ ニ タイスル プロスタグランディン I2 セイザイ オ モチイタ ニジ チリョウ ノ ケントウ

この論文をさがす

説明

We examined the effect of oral administration of beraprost sodium, a derivative of prostaglandin I2 (PGI2) in patients with sudden deafness as a salvage treatment after failure of initial systemic steroid therapy with prostaglandin E1. We then compared them with those of mecobalamin, a derivative of vitamin B12. A significant improvement in the average hearing level was obtained in patients who received beraprost sodium for 12 weeks, but not in patients who received mecobalamin. The hearing levels at 125 Hz, 250 Hz, 500 Hz and 8000 Hz significantly improved after the salvage treatment of beraprost sodium over those of mecobalamin. These findings suggested that oral administration of the PGI2 derivative could be utilized as a salvage treatment for refractory sudden deafness after failure of initial steroid therapy.<br>

収録刊行物

参考文献 (33)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ